Berlin-Chemie AG   Report issue

For profit Phase 3
Founded: Berlin Germany (1890)
Status: Acquired by Menarini Group (1992)

Organization Overview

First Clinical Trial
2013
NCT01880216
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

enoxaparin (lovenox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Thrombosis (Phase 3)

Venous Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1